Interior View of Hetero Biopharma manufacturing facility, Jadcherla, Hyderabad, India.
Vamsi Krishna Bandi believes that the Russian Sputnik-V vaccine has the potential to be a game-changer in India’s inoculation programme.(This story appears in the 04 June, 2021 issue of Forbes India. To visit our Archives, click here.)